Compared with wildtype, mice with Prx4−/− showed significantly lower rates in colon tumor incidence (Figure 2D), multiplicity (Figure 2E), volume (Figure 2F), and burden (Figure 2G). This evidence concerns the gene PRDX4 and colonic neoplasm.